JW Pharmaceutical Corp (001060):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:JW Pharmaceutical Corp (001060) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3485
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
JW Pharmaceutical Corp (JW Pharmaceutical), a subsidiary of JW Holdings Corp is a provider of generic drugs. The company develops and markets analgesics, antipyretics and cold remedy, antidote agents, antimicrobials, anticancer agents, and others. It offers multivitamins and antianemic agents, contact lens care and ophthalmic agents, antifungal agents, cardiovascular agents, and gastrointestinla agents. JW Pharmaceutical also offers topicals, amino acid solutions, flexible IV container, IV solutions, respiratory agents, obgy agents, nephrology agents, CNS, urology agents and diabetic agents. The company offers products for cardiovascular, gastrointestinal, nephrology or antianaemic, anticancer and neuropsychiatry. It operates through its production and manufacturing facilities in South Korea. JW Pharmaceutical is headquartered in Seoul, South Korea.

JW Pharmaceutical Corp (001060) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
JW Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
JW Pharmaceutical Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
JW Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
JW Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
JW Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
JW Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
JW Pharma Enters into Agreement with University of Pennsylvania 11
JW Pharmaceutical Enters into Co-Marketing Agreement with Ahn-Gook 12
JW Pharma Enters Into Agreement With Sanwa Kagaku Kenkyusho 13
JW Pharma Enters Into Co-Development Agreement With Pharmicell To Develop Stem Cell Therapy 14
Licensing Agreements 15
JW Pharma Enters into Licensing Agreement with EA Pharma 15
JW Pharma Enters into Licensing Agreement with Chugai Pharma 16
JW Pharma Enters into Licensing Agreement with Japan Tobacco 17
Equity Offering 18
JW Pharma Raises USD19 Million in Private Placement of Shares 18
Debt Offering 19
JW Pharma Completes Private Placement Of Bonds Due 2015 For US$27 Million 19
JW Pharma Completes Private Placement Of Bonds Due 2015 For US$17.8 Million 20
JW Pharmaceutical Corp – Key Competitors 21
JW Pharmaceutical Corp – Key Employees 22
JW Pharmaceutical Corp – Locations And Subsidiaries 23
Head Office 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
JW Pharmaceutical Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
JW Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
JW Pharmaceutical Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
JW Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
JW Pharmaceutical Corp, Deals By Therapy Area, 2012 to YTD 2018 8
JW Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
JW Pharma Enters into Agreement with University of Pennsylvania 11
JW Pharmaceutical Enters into Co-Marketing Agreement with Ahn-Gook 12
JW Pharma Enters Into Agreement With Sanwa Kagaku Kenkyusho 13
JW Pharma Enters Into Co-Development Agreement With Pharmicell To Develop Stem Cell Therapy 14
JW Pharma Enters into Licensing Agreement with EA Pharma 15
JW Pharma Enters into Licensing Agreement with Chugai Pharma 16
JW Pharma Enters into Licensing Agreement with Japan Tobacco 17
JW Pharma Raises USD19 Million in Private Placement of Shares 18
JW Pharma Completes Private Placement Of Bonds Due 2015 For US$27 Million 19
JW Pharma Completes Private Placement Of Bonds Due 2015 For US$17.8 Million 20
JW Pharmaceutical Corp, Key Competitors 21
JW Pharmaceutical Corp, Key Employees 22

List of Figures
JW Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
JW Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
JW Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
JW Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
JW Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
JW Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
JW Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
JW Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[JW Pharmaceutical Corp (001060):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Thirumalai Chemicals Limited (TIRUMALCHM):企業の財務・戦略的SWOT分析
    Thirumalai Chemicals Limited (TIRUMALCHM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Astronics Corp:企業の戦略・SWOT・財務情報
    Astronics Corp - Strategy, SWOT and Corporate Finance Report Summary Astronics Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Famy Care Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Famy Care Ltd (Famy Care) is a healthcare products provider that research, develops and manufactures female reproductive health care products. The company manufactures hormonal and reproductive health care products including famy care. Its hormonal formulation products include combined oral …
  • Pharmascience Inc-製薬・医療分野:企業M&A・提携分析
    Summary Pharmascience Inc (Pharmascience) is a pharmaceutical company that develops, manufactures and markets medicinal products. The company offers generic, prescription, over-the-counter and private label OTC products. It offers drugs in therapeutic areas of anti-inflammatory, cancer, cardiovascul …
  • South Jersey Industries, Inc. (SJI):石油・ガス:M&Aディール及び事業提携情報
    Summary South Jersey Industries Inc (SJI) is an energy services holding company that sources and supplies natural gas and electricity. It develops, owns, and operates on-site energy production facilities. The company provides wholesale commodity marketing and fuel management services; and also offer …
  • Syncardia Systems LLC:企業の戦略的SWOT分析
    Syncardia Systems LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Domain Therapeutics SA-製薬・医療分野:企業M&A・提携分析
    Summary Domain Therapeutics SA (Domain Therapeutics) is a biopharmaceutical company that discovers and develops innovative therapeutics for the treatment of Central Nervous System (CNS) diseases and cancer by using transmembrane and G Protein-Coupled Receptor (GPCR) platform. Its pipeline consists o …
  • Vijaya Bank:企業の戦略・SWOT・財務情報
    Vijaya Bank - Strategy, SWOT and Corporate Finance Report Summary Vijaya Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • BP Plc (BP.)-エネルギー分野:企業M&A・提携分析
    Summary BP p.l.c. (BP) is an integrated oil and gas company. It provides fuel, energy, lubricants and petrochemicals to its customers. Its upstream activities include oil and natural gas exploration, field development and production; and midstream operations include transportation, and marketing and …
  • Vertu Motors Plc:企業のM&A・事業提携・投資動向
    Vertu Motors Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Vertu Motors Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Cullinan Holdings Limited:企業の戦略・SWOT・財務分析
    Cullinan Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Cullinan Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Canara Bank:企業の戦略・SWOT・財務分析
    Canara Bank - Strategy, SWOT and Corporate Finance Report Summary Canara Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Abu Dhabi National Oil Co-石油・ガス分野:企業M&A・提携分析
    Summary Abu Dhabi National Oil Company (ADNOC) is a vertically integrated national oil and gas group. The group is active in exploration and production, support services, oil refining and gas processing, chemicals and petrochemicals, maritime transportation and refined products and distribution. ADN …
  • Turcas Petrol AS (TRCAS):企業の財務・戦略的SWOT分析
    Summary Turcas Petrol AS (Turcas) is an oil and gas company that distributes and markets lubricants and fuel products. The company operates in the fields of oil and energy, renewable energy, power investments, natural gas projects, fuel retail and lubricants distribution, and power generation and tr …
  • AMC Airlines:企業の戦略・SWOT・財務情報
    AMC Airlines - Strategy, SWOT and Corporate Finance Report Summary AMC Airlines - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Spectral Medical Inc (EDT):製薬・医療:M&Aディール及び事業提携情報
    Summary Spectral Medical Inc (Spectral), formerly Spectral Diagnostics Inc, is a biotechnology company that develops and commercializes diagnostic solutions for patient management. The company’s products comprise EAA, toraymyxin and reagents, among others. Its EAA is an endotoxin activity assay, whi …
  • Mizuno Corporation (8022):企業の財務・戦略的SWOT分析
    Mizuno Corporation (8022) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Aarhus University-製薬・医療分野:企業M&A・提携分析
    Summary Aarhus University (Aarhus) is a university that undertakes activities related to research, talent development, knowledge exchange and education. The university offers bachelor’s degree programmes, master’s degree programmes and PhD programmes in various disciplines. Its areas of academic int …
  • General Re Corporation:企業の戦略・SWOT・財務分析
    General Re Corporation - Strategy, SWOT and Corporate Finance Report Summary General Re Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • AeroControlex Group Inc.:企業の戦略・SWOT・財務情報
    AeroControlex Group Inc. - Strategy, SWOT and Corporate Finance Report Summary AeroControlex Group Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆